PDL BioPharma, Inc. Derivative Notional Amount
PDL BioPharma, Inc. had Derivative Notional Amount of $16.50 million as of 2015-12-31, per its 10-K filed 2016-02-23.
Discontinued › Notes › Derivative Instruments and Hedging Activities
invest:DerivativeNotionalAmount · last filed 2016-02-23
- 2015-12-31: Derivative, Notional Amount $16.50M.
- 2015-09-30: Derivative, Notional Amount $33.00M.
- 2015-06-30: Derivative, Notional Amount $49.13M.
- 2015-03-31: Derivative, Notional Amount $64.88M.
| Period end | Derivative, Notional Amount |
|---|---|
| 2015-12-31 | $16.50M 10-K · filed 2016-02-23 |
| 2015-09-30 | $33.00M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $49.13M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $64.88M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $85.88M 10-K · filed 2016-02-23 |
| 2014-09-30 | $38.27M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $58.67M 10-Q · filed 2014-08-18 |
| 2014-03-31 | $92.11M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $111.61M 10-K · filed 2015-02-23 |
| 2013-09-30 | $131.11M 10-Q · filed 2013-11-06 |
| 2012-12-31 | $210.67M 10-K · filed 2014-03-03 |